Logo

    tHEORetically speaking: Total System Value™ - A DYNAMIC APPROACH TO VALUE DEMONSTRATION

    en-usJanuary 08, 2024
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.

    Total System Value™ (TSV)™ is a new, dynamic framework designed to assess the value of adopting a new technology or policy initiative at a population level.

    For more information or to access other resources, click here

    Recent Episodes from tHEORetically speaking

    tHEORetically speaking: Patient-Centered Real-World Evidence in Rare Diseases

    tHEORetically speaking: Patient-Centered Real-World Evidence in Rare Diseases

    In this episode of tHEORetically Speaking, join Drs. Megan Gower and Edward Chou from Takeda, and Richard Tsai, MS from Inspire, who answer questions from a recent webinar on the challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases, to support clinical development through commercial post-approval.

    For more information, to watch the webinar, or access other resources, click here.

    tHEORetically speaking: Real-World Evidence Generation with Disease Registries

    tHEORetically speaking: Real-World Evidence Generation with Disease Registries

    In this episode of tHEORetically Speaking, join Drs. Javier Cid, Nahila Justo, and Delphine Saragoussi from Evidera and PPD, who answer questions from a recent webinar on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.

    For more information, to watch the webinar, or access other resources, click here.

    tHEORetically speaking: Clinical Outcome Assessment (COA) Translations

    tHEORetically speaking: Clinical Outcome Assessment (COA) Translations

    In this episode of tHEORetically speaking, join Christelle Giroudet, MA and Ana Alvarez, MA, COA Linguistic Validation Leaders with ICON, as they highlight the importance of Linguistic Validation and how equivalence should be a key focus during the development of Clinical Outcome Assessment translations.

    For more information, to watch the webinar, or access other resources, click here.

    tHEORetically speaking: Between Two Scientists - New Types of Data

    tHEORetically speaking: Between Two Scientists - New Types of Data

    This episode of tHEORetically Speaking is the third installment of Panalgo’s ‘Between Two Scientists’, featuring host Meg Richards, Executive Director of Solutions at Panalgo, who chats with Norstella’s General Manager of RWD, Ted Search, General Manager of RWD at Norstella about new types of unstructured real-world data and the challenges of incorporating them with structured data.

    Have a listen to the second ‘Between Two Scientists’ podcast which covered the privacy certification of linked data with Bobby Samuels of Datavant.

    For more information or to access other resources, click here

    tHEORetically speaking: Total System Value™ - A DYNAMIC APPROACH TO VALUE DEMONSTRATION

    tHEORetically speaking: Total System Value™ - A DYNAMIC APPROACH TO VALUE DEMONSTRATION

    HEOR Ltd. have been working on an exciting new framework called Total System Value™. This episode of tHEORetically speaking features their CEO Phil McEwan and CGO Jeff Anderson to talk to us about this dynamic approach to value demonstration.

    Total System Value™ (TSV)™ is a new, dynamic framework designed to assess the value of adopting a new technology or policy initiative at a population level.

    For more information or to access other resources, click here

    tHEORetically speaking: Between Two Scientists - Labeling and Certifying your Varietal Data Blend

    tHEORetically speaking: Between Two Scientists - Labeling and Certifying your Varietal Data Blend

    This episode of tHEORetically Speaking is the second installment of Panalgo's 'Between Two Scientists', featuring host Meg Richards, Executive Director of Solutions at Panalgo, and Bobby Samuels, General Manager of Privacy Hub at Datavant.

    In the first episode of ‘Between Two Scientists', we talked about data linkages and the need to certify the linked data before they can be used for research. In this episode, we’re picking up the data certification thread. Like the first episode, this one is also to wine-making.

    For more information or to access other resources, click here

    tHEORetically speaking: How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D

    tHEORetically speaking: How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D

    The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine at OM1, who discuss the path to personalized medicine and AI-powered clinical decision support in dermatology.

    For more information or to access other resources, click here

    tHEORetically speaking: The Future of Diversity in Clinical Trials: Real-World Evidence

    tHEORetically speaking: The Future of Diversity in Clinical Trials: Real-World Evidence

    This episode of tHEORetically Speaking features real-world evidence experts Alexandrina Balanean, Parisa Asgarisabet, and Danielle Gentile from Cardinal Health discussing the problems caused by lack of diverse representation in clinical trials.

    The underrepresentation of disproportionately burdened groups limits information on therapeutic response, safety, and efficacy to a small subset of the population—which tends to be healthier, more well-educated, and financially advantaged. However, recent findings show that real-world evidence (RWE) may be able to help with this underrepresentation. Listen in to learn more about these findings and what it may mean for the future of RWE.

    For more information or to access other resources, click here.

    tHEORetically speaking: Between Two Scientists - Data Linkage

    tHEORetically speaking: Between Two Scientists - Data Linkage

    This episode of tHEORetically Speaking features our host Meg Richards, Executive Director of Solutions at Panalgo, who will be speaking with Erik Maul, Senior Director of Data Partnerships at Panalgo about data linkage.

    The healthcare and life sciences industries are currently experiencing transformative times of growth. The explosion of real-world data, new regulatory programs and frameworks, and a focus on AI and machine learning are only a few of the factors contributing to this rapidly evolving landscape. In this podcast – we’re aiming to illuminate these catalysts of change by talking to the experts themselves. From tHEORetically Speaking, this is Episode 1 "Like Making a Fine, Blended Wine from Varietal Data Sources" of the Between Two Scientists series by Panalgo.

    For more information or to access other resources, click here

    tHEORetically speaking: Detecting and Decoding Alzheimer's with Real-World Data

    tHEORetically speaking: Detecting and Decoding Alzheimer's with Real-World Data

    The landscape for Alzheimer's disease is rapidly changing. This episode of tHEORetically speaking features Dr. Carl Marci from OM1 and Dr. Luke Stoeckel from NIA, as they discuss the critical need for earlier detection leading to potentially life changing earlier interventions.

    For more information or to access other resources, click here.

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io